Mike Sung

465 total citations
18 papers, 318 citations indexed

About

Mike Sung is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Mike Sung has authored 18 papers receiving a total of 318 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 9 papers in Oncology and 4 papers in Cancer Research. Recurrent topics in Mike Sung's work include Lung Cancer Treatments and Mutations (9 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Cancer Genomics and Diagnostics (4 papers). Mike Sung is often cited by papers focused on Lung Cancer Treatments and Mutations (9 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Cancer Genomics and Diagnostics (4 papers). Mike Sung collaborates with scholars based in Canada, United Kingdom and United States. Mike Sung's co-authors include Natasha B. Leighl, Frances A. Shepherd, Ronald Feld, Geoffrey Liu, Lisa W. Le, Penelope A. Bradbury, Leila Khoja, Alona Zer, Catherine Labbé and Manjula Maganti and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Journal of Thoracic Oncology.

In The Last Decade

Mike Sung

16 papers receiving 312 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mike Sung Canada	7	234	149	54	37	31	18	318
Davide Soldato Italy	10	192 0.8×	94 0.6×	56 1.0×	44 1.2×	19 0.6×	27	303
Elaine Yu United States	10	191 0.8×	102 0.7×	39 0.7×	33 0.9×	17 0.5×	34	314
Martine Bomb United Kingdom	6	226 1.0×	65 0.4×	31 0.6×	58 1.6×	23 0.7×	11	380
Anna Plym Sweden	12	124 0.5×	141 0.9×	42 0.8×	33 0.9×	15 0.5×	28	330
Sanna Iivanainen Finland	9	223 1.0×	85 0.6×	16 0.3×	26 0.7×	19 0.6×	34	287
Christopher Su United States	11	149 0.6×	114 0.8×	23 0.4×	41 1.1×	17 0.5×	30	297
Shalmali Bane United States	8	175 0.7×	88 0.6×	76 1.4×	16 0.4×	38 1.2×	17	315
U. Otto Germany	11	98 0.4×	138 0.9×	35 0.6×	31 0.8×	35 1.1×	36	278
Yngvar Nilssen Norway	11	210 0.9×	127 0.9×	29 0.5×	29 0.8×	12 0.4×	26	334

Countries citing papers authored by Mike Sung

Since Specialization

Citations

This map shows the geographic impact of Mike Sung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mike Sung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mike Sung more than expected).

Fields of papers citing papers by Mike Sung

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mike Sung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mike Sung. The network helps show where Mike Sung may publish in the future.

Co-authorship network of co-authors of Mike Sung

This figure shows the co-authorship network connecting the top 25 collaborators of Mike Sung. A scholar is included among the top collaborators of Mike Sung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mike Sung. Mike Sung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Sung, Mike, et al.. (2024). Efficient Terminology Integration for LLM-based Translation in Specialized Domains. 636–642.

Sung, Mike, et al.. (2024). Context-Aware LLM Translation System Using Conversation Summarization and Dialogue History. 1011–1015. 1 indexed citations

Law, Jennifer, Lisa W. Le, Janice J.N. Li, et al.. (2022). Automating Access to Real-World Evidence. JTO Clinical and Research Reports. 3(6). 100340–100340. 11 indexed citations

Sung, Mike, Pascale Tomasini, Lisa W. Le, et al.. (2021). Effects of Ethnicity on Outcomes of Patients With EGFR Mutation–Positive NSCLC Treated With EGFR Tyrosine Kinase Inhibitors and Surgical Resection. JTO Clinical and Research Reports. 3(2). 100259–100259. 3 indexed citations

Le, Lisa W., Sajjad Zahir, Janice J.N. Li, et al.. (2020). 1382P Automating access to real-world evidence. Annals of Oncology. 31. S879–S880. 1 indexed citations

Sung, Mike, Gilda da Cunha Santos, Lisa W. Le, et al.. (2020). Diagnostic Patterns of Non-Small-Cell Lung Cancer at Princess Margaret Cancer Centre. Current Oncology. 27(5). 244–249. 4 indexed citations

Sung, Mike, Alona Zer, Leila Khoja, et al.. (2020). Correlation of immune-related adverse events and response from immune checkpoint inhibitors in patients with advanced non-small cell lung cancer. Journal of Thoracic Disease. 12(5). 2706–2712. 23 indexed citations

Li, Janice J.N., Mike Sung, Lisa W. Le, et al.. (2020). Tobacco exposure and immunotherapy response in PD-L1 positive lung cancer patients. Lung Cancer. 150. 159–163. 31 indexed citations

Chen, Li‐Chia, Lan Le, Mike Sung, et al.. (2019). EP1.16-05 Real World Outcomes of Advanced NSCLC Patients with Liver Metastases. Journal of Thoracic Oncology. 14(10). S1066–S1066. 2 indexed citations

10.

Lau, Sally C. M., Lisa W. Le, Sze Wah Samuel Chan, et al.. (2019). Bone metastases as predictors of treatment response and rapidly progressive disease in NSCLC patients on PD-1/PD-L1 immune checkpoint inhibitors (ICI).. Journal of Clinical Oncology. 37(15_suppl). e20667–e20667. 1 indexed citations

11.

Zer, Alona, Mike Sung, Leila Khoja, et al.. (2018). Correlation of Neutrophil to Lymphocyte Ratio and Absolute Neutrophil Count With Outcomes With PD-1 Axis Inhibitors in Patients With Advanced Non–Small-Cell Lung Cancer. Clinical Lung Cancer. 19(5). 426–434.e1. 102 indexed citations

12.

Zer, Alona, Harman Sekhon, David Hwang, et al.. (2018). Translation of Knowledge to Practice—Improving Awareness in NSCLC Molecular Testing. Journal of Thoracic Oncology. 13(7). 1004–1011. 9 indexed citations

13.

Sung, Mike, Lisa W. Le, Frances A. Shepherd, et al.. (2017). Evolution of Symptom Burden of Advanced Lung Cancer Over a Decade. Clinical Lung Cancer. 18(3). 274–280.e6. 73 indexed citations

14.

Vogel, Arndt, Shukui Qin, Masatoshi Kudo, et al.. (2017). Health-Related Quality of Life (HRQOL) and Disease Symptoms in Patients with Unresectable Hepatocellular Carcinoma (HCC) Treated with Lenvatinib (LEN) or Sorafenib (SOR). Value in Health. 20(9). A454–A455. 4 indexed citations

15.

Marshall, John K., Neeraj Narula, Gerald Lebovic, et al.. (2017). P699 Impact of adalimumab's patient support program on clinical outcomes in inflammatory bowel diseases: results from the COMPANION study. Journal of Crohn s and Colitis. 11(suppl_1). S438–S439. 1 indexed citations

16.

Sung, Mike, et al.. (2016). Patients with Advanced Non–Small Cell Lung Cancer: Are Research Biopsies a Barrier to Participation in Clinical Trials?. Journal of Thoracic Oncology. 11(1). 79–84. 47 indexed citations

17.

Sung, Mike, et al.. (2016). Approach to Biomarker Testing: Perspectives from Various Specialties. Current Oncology. 23(3). 178–183. 5 indexed citations

18.

Sung, Mike, et al.. (2011). A technology for corrosion protection. 23(6). 23–26.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact